Cardiomyopathy and Myosin Studies
Cardiomyopathy and Myosin Studies is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 40k research works in it since 1950. 18.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, management, genetic basis, and clinical outcomes of hypertrophic cardiomyopathy. It explores topics such as cardiomyopathies, myosin mutations, left ventricular non-compaction, sudden death risk, cardiac imaging, titin mutations, dilated cardiomyopathy, and cardiac fibrosis.
- Cardiomyopathies
- Genetic Mutations
- Myosin
- Left Ventricular Non-Compaction
- Sudden Death Risk
- Cardiac Imaging
- Titin Mutations
- Dilated Cardiomyopathy
- Clinical Outcome
- Cardiac Fibrosis
- Research works
- 40k fractional, since 1950
- In the world top 10%
- 7.4k per year above
- Top-10% rate
- 18.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +13% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cardiomyopathy and Myosin Studies research?
By volume, the United States and China publish the most (2k and 648 works in 2022–2025).
By volume, 2022–2025
- 1 United States 2k works
- 2 China 648 works
- 3 Italy 385 works
- 4 United Kingdom 324 works
- 5 Japan 260 works
- 6 Germany 233 works
- 7 India 179 works
- 8 France 168 works
- 9 Spain 160 works
- 10 Brazil 150 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cardiomyopathy and Myosin Studies research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Cardiomyopathy and Myosin Studies research, followed by Mayo Clinic in Arizona and Cleveland Clinic.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 50 works
- 2 Mayo Clinic in ArizonaUnited States 42 works
- 3 Cleveland ClinicUnited States 40 works
- 4 University of PennsylvaniaUnited States 39 works
- 5 University of ArizonaUnited States 33 works
- 6 Stanford UniversityUnited States 28 works
- 7 University College LondonUnited Kingdom 28 works
- 8 University of WashingtonUnited States 27 works
- 9 Mayo ClinicUnited States 26 works
- 10 Fu Wai HospitalChina 23 works
Who are the leading researchers in Cardiomyopathy and Myosin Studies?
The most-cited researchers publishing on Cardiomyopathy and Myosin Studies include Valentı́n Fuster, Robert O. Bonow and Antônio Luiz Pinho Ribeiro.
- 1 Valentı́n Fuster United States 5.4k citations
- 2 Robert O. Bonow United States 4.5k citations
- 3 Antônio Luiz Pinho Ribeiro Brazil 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cardiomyopathy and Myosin Studies research done?
The largest centres of Cardiomyopathy and Myosin Studies research in 2022–2025 are London (United Kingdom), Beijing (China), New York (United States) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Scottsdale, Rochester and Trieste.
Largest cities, 2022–2025
Where it is the local speciality
- ScottsdaleUS · 41.8 works15×
- RochesterUS · 27.1 works11×
- TriesteIT · 22.4 works9.5×
Location quotient: how much more of its research is in Cardiomyopathy and Myosin Studies than the world average.
Where is the best place to study Cardiomyopathy and Myosin Studies?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, University of Pennsylvania and University of Padua score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 61.1 | 8.4% | 8.9× | 50 | +76.2% |
| 2 | University of PennsylvaniaUnited States | 61.1 | 18.2% | 7.4× | 39 | -13.3% |
| 3 | University of PaduaItaly | 59.5 | 25.8% | 4.7× | 22 | +17.7% |
| 4 | University of ArizonaUnited States | 57.3 | 10.8% | 8.7× | 33 | +38.0% |
| 5 | University of TriesteItaly | 56.7 | 19.0% | 10.4× | 11 | -23.2% |
| 6 | Oregon Health & Science UniversityUnited States | 56.3 | 9.8% | 10.5× | 19 | +94.8% |
| 7 | University of FlorenceItaly | 54.3 | 19.9% | 5.9× | 18 | +36.9% |
| 8 | University College LondonUnited Kingdom | 53.4 | 19.3% | 3.5× | 28 | -1.1% |
| 9 | Harvard UniversityUnited States | 52.1 | 24.9% | 2.7× | 20 | -10.6% |
| 10 | Semmelweis UniversityHungary | 50.8 | 7.9% | 12.2× | 14 | +55.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cardiomyopathy and Myosin Studies research growing?
Output in 2018–2022 was 13% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cardiomyopathy and Myosin Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.